We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.9B
AUM Growth
-$468M
(-2.7%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
1,101
New
144
Increased
331
Reduced
453
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$319M |
| 2 |
Uber
UBER
|
+$90.8M |
| 3 |
Tyson Foods
TSN
|
+$81.8M |
| 4 |
Archer Daniels Midland
ADM
|
+$81.5M |
| 5 |
Travelers Companies
TRV
|
+$81.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$106M |
| 2 |
Lockheed Martin
LMT
|
+$88.6M |
| 3 |
Ross Stores
ROST
|
+$77.9M |
| 4 |
Hilton Worldwide
HLT
|
+$69.3M |
| 5 |
Cigna
CI
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Financials | 12.87% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Protagonist Therapeutics
PTGX
$8.66B
| $2.15M | 0.01% |
129,011
-17,476
| -12% | -$339K |
|
552
Merchants Bancorp
MBIN
$2.58B
| $2.13M | 0.01% |
76,950
-7,435
| -9% | -$215K |
|
553
Inogen
INGN
$175M
| $2.08M | 0.01% |
399,323
+15,471
| +4% | +$110K |
|
554
Alignment Healthcare
ALHC
$3.84B
| $2.03M | 0.01% |
292,593
+112,572
| +63% | +$679K |
|
555
Cooper-Standard Automotive
CPS
$534M
| $2.01M | 0.01% |
149,572
-568
| -0.4% | -$9.01K |
|
556
Akebia Therapeutics
AKBA
$333M
| $1.96M | 0.01% |
1,719,061
+373,029
| +28% | +$479K |
|
557
Preferred Bank
PFBC
$1.25B
| $1.96M | 0.01% |
31,457
+25,372
| +417% | +$1.58M |
|
558
Nurix Therapeutics
NRIX
$2.43B
| $1.94M | 0.01% |
247,080
+200,184
| +427% | +$1.83M |
|
559
Pebblebrook Hotel Trust
PEB
$2.2B
| $1.93M | 0.01% |
142,285
-506,328
| -78% | -$7.26M |
|
560
Hyatt Hotels
H
$17.4B
| $1.93M | 0.01% |
18,209
-21,299
| -54% | -$2.42M |
|
561
Oscar Health
OSCR
$9.33B
| $1.92M | 0.01% |
+345,100
| New | +$2.41M |
|
|
VMEO
562
DELISTED
Vimeo
VMEO
| $1.92M | 0.01% |
541,191
-57,873
| -10% | -$229K |
|
563
Telos
TLS
$331M
| $1.91M | 0.01% |
798,930
-13,167
| -2% | -$30.2K |
|
564
Hartford Financial Services
HIG
$39.7B
| $1.9M | 0.01% |
+26,802
| New | +$1.95M |
|
565
Trustmark
TRMK
$2.76B
| $1.9M | 0.01% |
87,445
+9,590
| +12% | +$223K |
|
566
Stride
LRN
$4.14B
| $1.89M | 0.01% |
42,034
+8,501
| +25% | +$346K |
|
567
Clorox
CLX
$12.1B
| $1.88M | 0.01% |
+14,373
| New | +$2.18M |
|
|
AGNT
568
AGNT Inc
AGNT
$626M
| $1.88M | 0.01% |
115,581
+69,904
| +153% | +$1.44M |
|
569
1-800-Flowers.com
FLWS
$256M
| $1.86M | 0.01% |
266,205
-390,046
| -59% | -$2.93M |
|
570
MacroGenics
MGNX
$235M
| $1.86M | 0.01% |
399,484
-5,502
| -1% | -$27.4K |
|
571
Central Pacific Financial
CPF
$1.03B
| $1.86M | 0.01% |
111,298
-256
| -0.2% | -$4.37K |
|
572
Chesapeake Utilities
CPK
$3.29B
| $1.85M | 0.01% |
18,918
+4,993
| +36% | +$566K |
|
573
Preformed Line Products
PLPC
$1.37B
| $1.84M | 0.01% |
11,316
| – | – |
|
|
DSKE
574
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.84M | 0.01% |
358,004
-44,744
| -11% | -$270K |
|
575
John Wiley & Sons Class A
WLY
$2.85B
| $1.83M | 0.01% |
+49,101
| New | +$1.74M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2023 Portfolio in Review
As of Q3 2023, Jacobs Levy Equity Management held 1,101 positions worth $16.9B, down 2.7% from $17.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2023 filing shows 144 new, 331 increased, 453 reduced and 149 closed positions. Its largest new stake was Tyson Foods: 1,536,421 shares worth $77.6M. The largest sale was Altria Group, an estimated $106M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2023 buy was Tyson Foods: 1,536,421 shares worth $77.6M.
- Jacobs Levy Equity Management added most to NVIDIA in Q3 2023, an estimated $319M increase.
- Jacobs Levy Equity Management's biggest Q3 2023 reduction was Altria Group, cutting an estimated $106M.
- Jacobs Levy Equity Management fully exited Hilton Worldwide in Q3 2023, selling an estimated $69.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $16.9B portfolio in Q3 2023.
- Jacobs Levy Equity Management opened 144 new positions and closed 149 in Q3 2023.
- Jacobs Levy Equity Management's portfolio value fell 2.7% quarter-over-quarter to $16.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.